updates
Portfolio and APVC news
Neuspera Receives FDA Approval for First Integrated Sacral Neuromodulation (iSNM) System for Urinary Urge Incontinence
Connecticut Passes Law to Establish $2M Center of Excellence to provide Veterans with MicroTransponder’s Vivistim Therapy for Stroke Recovery
Presidio Medical Receives IDE Approval for Ultra Low Frequency (ULF) Neuromodulation Clinical Study
Setpoint Medical Receives Clinical Research Award at EULAR 2025 Congress
Setpoint Medical Appoints Tyler Binney to its Board of Directors
Exo Announces Samsung Medison Strategic Partnership; Omar Ishrak Joins Exo Board
Alpheus Medical Raises $52M in Ser B Round to Advance Groundbreaking Glioblastoma Therapy
Chronic Stroke Survivors Demonstrate Long-Term Improvement in Motor Impairment with Vivistim Therapy
Cala Presents Multiple Clinical Studies Demonstrating Impact of TAPS Therapy in Essential Tremor (ET) at American Academy of Neurology (AAN)